Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Bromodomain Containing Protein 4 Therapeutic Pipeline Market Review, H2 2016

Thursday, September 22, 2016 3:13
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Bromodomain Containing Protein 4 Therapeutic Market 2016

Complete Report Details @ https://www.wiseguyreports.com/reports/649748-bromodomain-containing-protein-4-protein-hunk1-or-brd4-pipeline-review-h2-2016

The, ‘Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) – Pipeline Review, H2 2016’, provides in depth analysis on Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted pipeline therapeutics.

The report provides comprehensive information on the Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics development and features dormant and discontinued projects.

For more information or any query mail at sales@wiseguyreports.com

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/649748-bromodomain-containing-protein-4-protein-hunk1-or-brd4-pipeline-review-h2-2016

Scope

- The report provides a snapshot of the global therapeutic landscape for Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) 
- The report reviews Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics and enlists all their major and minor projects 
- The report assesses Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news and deals related to Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand the targeted therapy areas and indications for Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) 
- Identify the use of drugs for target identification and drug repurposing 
- Identify potential new clients or partners in the target demographic 
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) development landscape 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table Of Contents – Major Key Points

#Companies Involved in Therapeutics Development:

Aptose Biosciences Inc. 29 
Arvinas, Inc. 30 
C4 Therapeutics, Inc. 31 
Constellation Pharmaceuticals, Inc. 32 
ConverGene, LLC 33 
Daiichi Sankyo Company, Limited 34 
Dybly AG 35 
F. Hoffmann-La Roche Ltd. 36 
Incyte Corporation 37 
Kainos Medicine, Inc. 38 
Merck & Co., Inc. 39 
Resverlogix Corp. 40 
Trillium Therapeutics Inc. 41 
Zenith Epigenetics Corp 42 

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) – Drug Profiles 43 
apabetalone – Drug Profile 43 
Product Description 43 
Mechanism Of Action 43 
R&D Progress 43 
ARV-763 – Drug Profile 52 
Product Description 52 
Mechanism Of Action 52 
R&D Progress 52 
ARV-771 – Drug Profile 53 
Product Description 53 
Mechanism Of Action 53 
R&D Progress 53 
ARV-825 – Drug Profile 54 
Product Description 54 
Mechanism Of Action 54 
R&D Progress 54 
birabresib – Drug Profile 55 
Product Description 55 
Mechanism Of Action 55 
R&D Progress 55 
CK-103 – Drug Profile 57 
Product Description 57 
Mechanism Of Action 57 
R&D Progress 57 
CPI-0610 – Drug Profile 58 
Product Description 58 
Mechanism Of Action 58 
R&D Progress 58 
CVG-101 – Drug Profile 59 
Product Description 59 
Mechanism Of Action 59 
R&D Progress 59 
DYB-186 – Drug Profile 60 
Product Description 60 
Mechanism Of Action 60 
R&D Progress 60 
INCB-54329 – Drug Profile 61 
Product Description 61 
Mechanism Of Action 61 
R&D Progress 61 
KM-601 – Drug Profile 62 
Product Description 62 
Mechanism Of Action 62 
R&D Progress 62 
MA-2014 – Drug Profile 63 
Product Description 63 
Mechanism Of Action 63 

…….CONTUNUED

For more information or any query mail at sales@wiseguyreports.com

Get Exclusive Discount On This Report @ https://www.wiseguyreports.com/check-discount/649748-bromodomain-containing-protein-4-protein-hunk1-or-brd4-pipeline-review-h2-2016

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

ABOUT US:

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.